SCHEMBL29028875

SCHEMBL29028875

O=C(O)c1ccc(C(F)(F)F)c(Br)n1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ASPH Q12797 1/20 0.42
KDM4E B2RXH2 5/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
ACMSD Q8TDX5 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 2/20 0.40
KMO O15229 4/20 0.39
MGAM O43451 1/20 0.39
DAO P14920 1/20 0.39
CFTR P13569 2/20 0.39
MRGPRX4 Q96LA9 1/20 0.37
EPRS1 P07814 1/20 0.37
CNR2 P34972 1/20 0.36
KMT2A Q03164 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16224717 0.80 NOTUM (0.53) KDM4EALDH1A1CFTRMRGPRX4
SCHEMBL29378647 0.80 NOTUM (0.53) KDM4EALDH1A1CFTRMRGPRX4
SCHEMBL27655824 0.79 KDM4E (0.43) ASPHKDM4EALOX15TSHRACMSD
SCHEMBL3881447 0.78 KDM4E (0.51) ASPHKDM4EALOX15TSHRACMSD
SCHEMBL6255502 0.78 XPO1 (0.47) ASPHKDM4EALOX15TSHRACMSD
SCHEMBL3214818 0.76 CYP1A2 (0.53) KDM4EALDH1A1CNR2KMT2AL3MBTL1
SCHEMBL6258123 0.75 ASPH (0.40) ASPHKDM4EALOX15TSHRACMSD
SCHEMBL27655838 0.75 KMO (0.38) ASPHKDM4EALOX15TSHRACMSD
SCHEMBL30601029 0.75 KDM4E (0.46) ASPHKDM4EALOX15TSHRACMSD
SCHEMBL319252 0.75 KDM4E (0.46) ASPHKDM4EALOX15TSHRACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670140-A Macrocyclic compounds containing 1,3, 4-oxadiazole rings as modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-08-29 CN disclosed
EP-4192829-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-06-14 EP disclosed
CN-116171154-A Modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-05-26 CN disclosed
WO-2022032068-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-02-10 WO disclosed